Showing results (101-110 of 1,698) with videos related to
Sort By:
Pageof 170
The Prostate|January 11, 1990
Dunning rat prostate tumors and cultured cell lines fail to express human prostate carcinoma-associated antigensK R Newhall, J T Isaacs, G L WrightThe Prostate|January 1, 1990
Differential effects of growth factor antagonists on neoplastic and normal prostatic cellsR A Morton, J T Isaacs, W B IsaacsInvestigative Urology|May 1, 1981
Differences in the effects of estradiol on dihydrotestosterone induced prostatic growth of the castrate dog and ratR J Ehrlichman, J T Isaacs, D S CoffeySteroids|February 1, 1980
The identification and characterization of the C19O3 steroid metabolites of 5 alpha-androstane-3 beta,17 beta-diol produced by the canine prostate: 5 alpha-androstane-3 beta,6 alpha,17 beta-triol and 5 alpha-androstane-3 beta,7 alpha,17 beta-triolJ T Isaacs, I R McDermott, D S CoffeyCurrent Opinion in Oncology|January 1, 1997
Molecular advances in prostate cancerJ T Dong, W B Isaacs, J T IsaacsCancer Research|July 1, 1979
Models for development of nonreceptor methods for distinguishing androgen-sensitive and -insensitive prostatic tumorsJ T Isaacs, W B Isaacs, D S CoffeyThe Prostate|January 1, 1987
Response of glandular versus basal rat ventral prostatic epithelial cells to androgen withdrawal and replacementH F English, R J Santen, J T IsaacsThe Journal of Clinical Endocrinology and Metabolism|January 1, 1983
Changes in the metabolism of dihydrotestosterone in the hyperplastic human prostateJ T Isaacs, C B Brendler, P C WalshOncogene|March 17, 2015
CCAAT/Enhancer binding protein β controls androgen-deprivation-induced senescence in prostate cancer cellsD J Barakat, J Zhang, T Barberi, et al.Cancer Research|August 28, 2001
Therapeutic implications of enhanced G(0)/G(1) checkpoint control induced by coculture of prostate cancer cells with osteoblastsJ Pinski, A Parikh, G S Bova, et al.Pageof 170